Baudax Bio Inc (BXRXQ)
OTCMKTS: BXRXQ · Delayed Price · USD
0.0063
-0.0012 (-16.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Baudax Bio Market Cap
Baudax Bio has a market cap or net worth of $50.36 thousand as of July 2, 2024. Its market cap has decreased by -98.56% in one year.
Market Cap
50.36K
Enterprise Value
7.79M
1-Year Change
-98.56%
Ranking
n/a
Category
Stock Price
$0.01
Market Cap Chart
Since November 14, 2019, Baudax Bio's market cap has decreased from $66.10M to $50.36K, a decrease of -99.92%. That is a compound annual growth rate of -83.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 15, 2023 | 1.30M | -18.75% |
| Dec 30, 2022 | 1.60M | -91.35% |
| Dec 31, 2021 | 18.50M | -30.19% |
| Dec 31, 2020 | 26.50M | -59.42% |
| Dec 31, 2019 | 65.30M | -1.21% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 859.48B |
| Novo Nordisk | 626.17B |
| UnitedHealth Group | 457.69B |
| Johnson & Johnson | 351.46B |
| Merck & Co. | 323.21B |
| AbbVie | 294.05B |
| AstraZeneca | 238.82B |
| Novartis AG | 208.31B |